IL18R1 and neoplasm: Among these, the IL-17 signaling pathway and cytokine–cytokine receptor interactions were particularly relevant, as they play crucial roles in immune responses and inflammation, suggesting their contribution to the anti-tumor effects triggered by eCPMV immunotherapy treatment.